12 Health Care Stocks Moving In Wednesday's After-Market Session

Benzinga Insights 4 hours ago

Movers

Gainers Revolution Medicines (NASDAQ:RVMD) stock rose 14.1% to $227.83 during Wednesday's after-market session. The market value of their outstanding shares is at $41.6 billion. As per the news, the Q3 earnings

Gainers

  • Revolution Medicines (NASDAQ:RVMD) stock rose 14.1% to $227.83 during Wednesday's after-market session. The market value of their outstanding shares is at $41.6 billion. As per the news, the Q3 earnings report came out today.
  • Maravai LifeSciences (NASDAQ:MRVI) shares increased by 9.19% to $8.43. The company's market cap stands at $1.1 billion. As per the press release, Q3 earnings came out today.
  • Erasca (NASDAQ:ERAS) stock increased by 7.31% to $16.0. The company's market cap stands at $5.1 billion.
  • ADMA Biologics (NASDAQ:ADMA) stock moved upwards by 6.87% to $11.2. The market value of their outstanding shares is at $2.4 billion. As per the press release, Q3 earnings came out today.
  • Nano X Imaging (NASDAQ:NNOX) shares moved upwards by 6.02% to $0.3. The market value of their outstanding shares is at $24.0 million.
  • Karyopharm Therapeutics (NASDAQ:KPTI) stock increased by 4.38% to $0.08. The company's market cap stands at $2.0 million.

Losers

  • GRAIL (NASDAQ:GRAL) shares fell 18.6% to $117.0 during Wednesday's after-market session. The market value of their outstanding shares is at $6.2 billion. As per the news, the Q3 earnings report came out today.
  • Arcutis Biotherapeutics (NASDAQ:ARQT) shares declined by 7.85% to $31.38. The company's market cap stands at $4.0 billion. As per the news, the Q3 earnings report came out today.
  • Curis (NASDAQ:CRIS) shares decreased by 6.76% to $1.03. The market value of their outstanding shares is at $1.7 million.
  • Equillium (NASDAQ:EQ) stock declined by 5.0% to $1.33. The company's market cap stands at $110.4 million.
  • Heron Therapeutics (NASDAQ:HRTX) shares declined by 4.89% to $0.28. The company's market cap stands at $54.0 million.
  • Cue Biopharma (NASDAQ:CUE) stock decreased by 4.24% to $19.0. The company's market cap stands at $151.5 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Read the original